Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Training program in vaccine development and public health
Provide Comprehensive Animal Care
Analysis of Epidemiologic Study Data
Biomedical Research Support
Marital Instability Over the Life Course
Recently added grants:
Mechanisms regulating neural stem cell maintenance in the dentate gyrus
Language Input as a Mechanism Underlying Socioeconomic Disparities in Neurocognitive Development
Systematic identification of RNA sequences and protein components regulating circular RNA translation
Improving Diversity in Neonatal Clinical Trial Enrollment
Dynamic Regulatory Processes in the Transition from Suicidal Ideation to Action: The Roles of Cognitive Control, Emotion-Related Impulsivity, and Sleep in the Context of Negative Affective Experiences
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35000-8-0-1
Application #
7579487
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Mayo Clinic, Rochester
$2,258,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Limburg, Paul J. /
$2,257,713
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant